Cypre Inc.
PrivateLast Round
Seed Round
Jan 10, 2024
Total Funding Raised
$150,000
Momentum Score
50 /100
Company Overview
Cypre Inc. is a biotechnology company developing a 3D tumor modeling platform designed to improve the process of cancer drug development and precision medicine.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Advanced Materials, 3D Printing
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cypre Inc. Comps
Public and private peers based on sector, stage, and business model.
Cypre Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jan 10, 2024 | ||||
| Seed | Aug 24, 2018 |
Cypre Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MBC BioLabs | Seed |
| Kluz Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors grew 1891% MoM, from 79 to 1.6K.
- Jan 10, 2024
Raised $1.7M in a Seed Round.
Cypre Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cypre Inc.'s valuation, stock price, and market status.
